Showing results (141-150 of 438) with videos related to

Sort By:
Pageof 44
European Journal of Cancer (Oxford, England : 1990)|April 8, 2026
From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancerMargherita Ambrosini, Claire Gallois, Annalice Gandini, et al.
Clinical Colorectal Cancer|March 9, 2019
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual InhibitionLorenza Rimassa, Silvia Bozzarelli, Filippo Pietrantonio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 29, 2023
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to actionLorenzo Fornaro, Sara Lonardi, Silvia Catanese, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
Pathology, Research and Practice|February 12, 2023
Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinomaFederica Zannier, Valentina Angerilli, Gaya Spolverato, et al.
British Journal of Cancer|September 20, 2017
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trialRiccardo Giampieri, Marco Puzzoni, Bruno Daniele, et al.
Plos One|September 24, 2020
A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancerYuji Miyamoto, Marta Schirripa, Mitsukuni Suenaga, et al.
Cancer Treatment Reviews|August 25, 2019
Gastric cancer: Translating novels concepts into clinical practiceMassimiliano Salati, Giulia Orsi, Elisabeth Smyth, et al.
Pathology, Research and Practice|December 26, 2024
MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinomaCarlotta Ceccon, Chiara Borga, Valentina Angerilli, et al.
Pageof 44